Do analysts prefer MOGU or ISPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MOGU 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, MOGU or ISPC?

MOGU has higher revenue and earnings than iSpecimen. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio MOGU $18.18M 0.80 $270K N/A N/A iSpecimen $1.93M 1.58 -$10.49M -$72.26 N/A

Is MOGU or ISPC more profitable?

MOGU has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. MOGU's return on equity of 0.00% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets MOGU N/A N/A N/A iSpecimen -1,080.16% -584.65% -142.48%

Do analysts prefer ISPC or BTOC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Armlogi 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings & valuation, ISPC or BTOC?

iSpecimen has higher earnings, but lower revenue than Armlogi. Armlogi is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iSpecimen $1.93M 1.58 -$10.49M -$72.26 N/A Armlogi $190.41M 0.06 -$15.35M -$0.47 N/A

Is ISPC or BTOC more profitable?

Armlogi has a net margin of -10.70% compared to iSpecimen's net margin of -1,080.16%. Armlogi's return on equity of -104.33% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets iSpecimen -1,080.16% -584.65% -142.48% Armlogi -10.70% -104.33% -13.30%

Do analysts rate ISPC or CIGL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Concorde International Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, ISPC or CIGL?

iSpecimen has higher earnings, but lower revenue than Concorde International Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iSpecimen $1.93M 1.58 -$10.49M -$72.26 N/A Concorde International Group $12.48M 8.16 -$15.24M N/A N/A

Do analysts recommend CISO or ISPC?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CISO Global 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings and valuation, CISO or ISPC?

CISO Global has higher revenue and earnings than iSpecimen. CISO Global is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CISO Global $26.61M 0.43 -$8.07M -$0.24 N/A iSpecimen $1.93M 1.58 -$10.49M -$72.26 N/A

Is CISO or ISPC more profitable?

CISO Global has a net margin of -16.69% compared to iSpecimen's net margin of -1,080.16%. CISO Global's return on equity of -32.61% beat iSpecimen's return on equity. Company Net Margins Return on Equity Return on Assets CISO Global -16.69% -32.61% -17.19% iSpecimen -1,080.16% -584.65% -142.48%

Do analysts rate ISPC or SFHG?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iSpecimen 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Samfine Creation Holdings Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, ISPC or SFHG?

Samfine Creation Holdings Group has higher revenue and earnings than iSpecimen. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iSpecimen $1.93M 1.58 -$10.49M -$72.26 N/A Samfine Creation Holdings Group $169.79M 0.06 -$2.55M N/A N/A

iSpecimen (ISPC) Competitors

$2.01 +0.04 (+2.03%)

Closing price 04:00 PM Eastern

Extended Trading

$2.01 0.00 (0.00%)

As of 05:03 PM Eastern

Compare

ISPC vs. MOGU, BTOC, CIGL, CISO, and SFHG

Should you buy iSpecimen stock or one of its competitors? MarketBeat compares iSpecimen with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with iSpecimen include MOGU (MOGU), Armlogi (BTOC), Concorde International Group (CIGL), CISO Global (CISO), and Samfine Creation Holdings Group (SFHG). These companies are all part of the "business services" industry.

How does iSpecimen compare to MOGU?

MOGU (NYSE:MOGU) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends, earnings and media sentiment.

MOGU has higher revenue and earnings than iSpecimen.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MOGU	$18.18M	0.80	$270K	N/A	N/A
iSpecimen	$1.93M	1.58	-$10.49M	-$72.26	N/A

In the previous week, MOGU had 1 more articles in the media than iSpecimen. MarketBeat recorded 2 mentions for MOGU and 1 mentions for iSpecimen. iSpecimen's average media sentiment score of 1.89 beat MOGU's score of -0.50 indicating that iSpecimen is being referred to more favorably in the news media.

Company	Overall Sentiment
MOGU	Negative
iSpecimen	Very Positive

MOGU has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. MOGU's return on equity of 0.00% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MOGU	N/A	N/A	N/A
iSpecimen	-1,080.16%	-584.65%	-142.48%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MOGU	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

19.1% of MOGU shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 19.8% of MOGU shares are owned by insiders. Comparatively, 12.2% of iSpecimen shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

MOGU has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market. Comparatively, iSpecimen has a beta of 1.63, indicating that its stock price is 63% more volatile than the broader market.

Summary

MOGU beats iSpecimen on 8 of the 11 factors compared between the two stocks.

How does iSpecimen compare to Armlogi?

iSpecimen (NASDAQ:ISPC) and Armlogi (NASDAQ:BTOC) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations and earnings.

iSpecimen has higher earnings, but lower revenue than Armlogi. Armlogi is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$1.93M	1.58	-$10.49M	-$72.26	N/A
Armlogi	$190.41M	0.06	-$15.35M	-$0.47	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Armlogi	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Armlogi has a net margin of -10.70% compared to iSpecimen's net margin of -1,080.16%. Armlogi's return on equity of -104.33% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iSpecimen	-1,080.16%	-584.65%	-142.48%
Armlogi	-10.70%	-104.33%	-13.30%

iSpecimen has a beta of 1.63, indicating that its share price is 63% more volatile than the broader market. Comparatively, Armlogi has a beta of 2.75, indicating that its share price is 175% more volatile than the broader market.

13.6% of iSpecimen shares are held by institutional investors. 12.2% of iSpecimen shares are held by insiders. Comparatively, 66.9% of Armlogi shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, iSpecimen and iSpecimen both had 1 articles in the media. iSpecimen's average media sentiment score of 1.89 beat Armlogi's score of 1.87 indicating that iSpecimen is being referred to more favorably in the media.

Company	Overall Sentiment
iSpecimen	Very Positive
Armlogi	Very Positive

Summary

Armlogi beats iSpecimen on 7 of the 12 factors compared between the two stocks.

How does iSpecimen compare to Concorde International Group?

iSpecimen (NASDAQ:ISPC) and Concorde International Group (NASDAQ:CIGL) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

In the previous week, Concorde International Group had 3 more articles in the media than iSpecimen. MarketBeat recorded 4 mentions for Concorde International Group and 1 mentions for iSpecimen. iSpecimen's average media sentiment score of 1.89 beat Concorde International Group's score of 0.15 indicating that iSpecimen is being referred to more favorably in the media.

Company	Overall Sentiment
iSpecimen	Very Positive
Concorde International Group	Neutral

13.6% of iSpecimen shares are owned by institutional investors. 12.2% of iSpecimen shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Concorde International Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Concorde International Group has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Concorde International Group's return on equity of 0.00% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iSpecimen	-1,080.16%	-584.65%	-142.48%
Concorde International Group	N/A	N/A	N/A

iSpecimen has a beta of 1.63, indicating that its stock price is 63% more volatile than the broader market. Comparatively, Concorde International Group has a beta of 2.76, indicating that its stock price is 176% more volatile than the broader market.

iSpecimen has higher earnings, but lower revenue than Concorde International Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$1.93M	1.58	-$10.49M	-$72.26	N/A
Concorde International Group	$12.48M	8.16	-$15.24M	N/A	N/A

Summary

Concorde International Group beats iSpecimen on 7 of the 11 factors compared between the two stocks.

How does iSpecimen compare to CISO Global?

CISO Global (NASDAQ:CISO) and iSpecimen (NASDAQ:ISPC) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

CISO Global has a net margin of -16.69% compared to iSpecimen's net margin of -1,080.16%. CISO Global's return on equity of -32.61% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CISO Global	-16.69%	-32.61%	-17.19%
iSpecimen	-1,080.16%	-584.65%	-142.48%

CISO Global has a beta of 1.74, meaning that its stock price is 74% more volatile than the broader market. Comparatively, iSpecimen has a beta of 1.63, meaning that its stock price is 63% more volatile than the broader market.

40.1% of CISO Global shares are owned by institutional investors. Comparatively, 13.6% of iSpecimen shares are owned by institutional investors. 23.8% of CISO Global shares are owned by insiders. Comparatively, 12.2% of iSpecimen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, CISO Global had 2 more articles in the media than iSpecimen. MarketBeat recorded 3 mentions for CISO Global and 1 mentions for iSpecimen. iSpecimen's average media sentiment score of 1.89 beat CISO Global's score of 0.63 indicating that iSpecimen is being referred to more favorably in the news media.

Company	Overall Sentiment
CISO Global	Positive
iSpecimen	Very Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CISO Global	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

CISO Global has higher revenue and earnings than iSpecimen. CISO Global is trading at a lower price-to-earnings ratio than iSpecimen, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CISO Global	$26.61M	0.43	-$8.07M	-$0.24	N/A
iSpecimen	$1.93M	1.58	-$10.49M	-$72.26	N/A

Summary

CISO Global beats iSpecimen on 10 of the 13 factors compared between the two stocks.

How does iSpecimen compare to Samfine Creation Holdings Group?

iSpecimen (NASDAQ:ISPC) and Samfine Creation Holdings Group (NASDAQ:SFHG) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment and earnings.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iSpecimen	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Samfine Creation Holdings Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, iSpecimen and iSpecimen both had 1 articles in the media. Samfine Creation Holdings Group's average media sentiment score of 1.90 beat iSpecimen's score of 1.89 indicating that Samfine Creation Holdings Group is being referred to more favorably in the news media.

Company	Overall Sentiment
iSpecimen	Very Positive
Samfine Creation Holdings Group	Very Positive

13.6% of iSpecimen shares are held by institutional investors. 12.2% of iSpecimen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

iSpecimen has a beta of 1.63, meaning that its share price is 63% more volatile than the broader market. Comparatively, Samfine Creation Holdings Group has a beta of 2.08, meaning that its share price is 108% more volatile than the broader market.

Samfine Creation Holdings Group has higher revenue and earnings than iSpecimen.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iSpecimen	$1.93M	1.58	-$10.49M	-$72.26	N/A
Samfine Creation Holdings Group	$169.79M	0.06	-$2.55M	N/A	N/A

Samfine Creation Holdings Group has a net margin of 0.00% compared to iSpecimen's net margin of -1,080.16%. Samfine Creation Holdings Group's return on equity of 0.00% beat iSpecimen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iSpecimen	-1,080.16%	-584.65%	-142.48%
Samfine Creation Holdings Group	N/A	N/A	N/A

Summary

Samfine Creation Holdings Group beats iSpecimen on 7 of the 10 factors compared between the two stocks.

Get iSpecimen News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ISPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ISPC vs. The Competition

Export

Metric	iSpecimen	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.06M	$9.69B	$6.96B	$12.17B
Dividend Yield	N/A	1.63%	2.67%	9.81%
P/E Ratio	-0.03	25.70	27.16	23.75
Price / Sales	1.58	19.29	530.35	92.13
Price / Cash	N/A	14.92	26.45	46.67
Price / Book	0.14	6.13	10.49	6.16
Net Income	-$10.49M	$182.36M	$3.61B	$331.26M
7 Day Performance	-13.36%	-1.75%	-1.29%	-0.07%
1 Month Performance	-24.72%	-1.26%	-2.62%	-2.53%
1 Year Performance	-95.30%	10.90%	18.61%	13.92%

iSpecimen Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ISPC iSpecimen	0.7758 of 5 stars	$2.01 +2.0%	N/A	-95.4%	$3.06M	$1.93M	N/A	60
MOGU MOGU	0.8278 of 5 stars	$1.85 -4.9%	N/A	-8.9%	$13.97M	$18.18M	N/A	470	News Coverage Short Interest Increase
BTOC Armlogi	0.7412 of 5 stars	$0.30 +1.4%	N/A	-84.2%	$13.36M	$190.41M	N/A	N/A	Positive News Gap Down
CIGL Concorde International Group	N/A	$0.57 -4.7%	N/A	-84.5%	$12.67M	$11.07M	N/A	134
CISO CISO Global	0.8945 of 5 stars	$0.27 -0.7%	N/A	-76.1%	$12.23M	$26.61M	N/A	443

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ISPC) was last updated on 7/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

iSpecimen (ISPC) Competitors

ISPC vs. MOGU, BTOC, CIGL, CISO, and SFHG

How does iSpecimen compare to MOGU?

Summary

How does iSpecimen compare to Armlogi?

Summary

How does iSpecimen compare to Concorde International Group?

Summary

How does iSpecimen compare to CISO Global?

Summary

How does iSpecimen compare to Samfine Creation Holdings Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ISPC vs. The Competition

iSpecimen Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

iSpecimen (ISPC) Competitors

ISPC vs. MOGU, BTOC, CIGL, CISO, and SFHG

How does iSpecimen compare to MOGU?

Which has preferable valuation & earnings, MOGU or ISPC?

Does the media prefer MOGU or ISPC?

Is MOGU or ISPC more profitable?

Do analysts prefer MOGU or ISPC?

Do institutionals and insiders hold more shares of MOGU or ISPC?

Which has more volatility and risk, MOGU or ISPC?

Summary

How does iSpecimen compare to Armlogi?

Which has stronger earnings & valuation, ISPC or BTOC?

Do analysts prefer ISPC or BTOC?

Is ISPC or BTOC more profitable?

Which has more volatility & risk, ISPC or BTOC?

Do institutionals & insiders believe in ISPC or BTOC?

Does the media favor ISPC or BTOC?

Summary

How does iSpecimen compare to Concorde International Group?

Does the media favor ISPC or CIGL?

Do insiders and institutionals hold more shares of ISPC or CIGL?

Do analysts rate ISPC or CIGL?

Is ISPC or CIGL more profitable?

Which has more risk & volatility, ISPC or CIGL?

Which has higher earnings & valuation, ISPC or CIGL?

Summary

How does iSpecimen compare to CISO Global?

Is CISO or ISPC more profitable?

Which has more volatility and risk, CISO or ISPC?

Do insiders & institutionals have more ownership in CISO or ISPC?

Does the media refer more to CISO or ISPC?

Do analysts recommend CISO or ISPC?

Which has better earnings and valuation, CISO or ISPC?

Summary

How does iSpecimen compare to Samfine Creation Holdings Group?

Do analysts rate ISPC or SFHG?

Does the media prefer ISPC or SFHG?

Do insiders & institutionals have more ownership in ISPC or SFHG?

Which has more volatility & risk, ISPC or SFHG?

Which has better earnings & valuation, ISPC or SFHG?

Is ISPC or SFHG more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ISPC vs. The Competition

iSpecimen Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools